ESC Congress 2025

Thank you to everyone who joined Roche at ESC Congress 2025 in Madrid! We hope you enjoyed discovering how we are transforming the cardiac care continuum — from early diagnosis to personalized treatment and long-term monitoring. We look forward to seeing you at future events.
 

Delivering holistic care for people living with cardiometabolic conditions - from diagnosis to treatment to ongoing monitoring
 

As the leader in in vitro diagnostics, we discover and develop novel, high-quality, accurate assays, point-of-care devices, and digital solutions to deliver on unmet medical needs. Our goal is to enable excellence in patient-centric decision-making and help tackle the high burden of Cardiometabolic diseases in our society.
 

Highlights of the booth

The event was a premier opportunity to explore the forefront of medical innovation. The immersive experience at our booth showcased:
 

The Medical Corner - Advancing CVRM drug development
 

A Medical Corner to explore how Roche is contributing to the future of CVRM treatment through data-driven research and collaborative innovation.
 

Clinical Dialogue with Leaders
 

Direct conversations with Roche scientists and clinical experts to learn about our latest breakthroughs, ask questions, and exchange perspectives on improving cardiometabolic care.

Product showcases – Explore more
 

• Elecsys® Troponin T hs Gen 6 – A new benchmark for high-sensitivity Troponin testing. Our next-generation high-sensitivity Troponin T assay, designed to optimize the diagnostic process of myocardial infarction and support confident clinical decision-making.
• LumiraDx: Our newest point-of-care system in action, the cutting-edge, portable diagnostic solution designed to radically simplify diagnostics and reshape the healthcare journey for patients and professionals at the Point of Need.
• Lp(a) Assay and its role in residual cardiovascular risk — how our assay enables better risk stratification.